|
verdict out to some
After seeing both my onc and surgeon in a one week time frame, it seems both of them, (at different hospitals by the way), feel that there is still more to learn and find out about tykerb,(lapatinib), before they can be comfortable with it. They both commented on the way the trial was done and said there was a missing arm to the trial that should have been run. They both said it will be some time before they will know for sure tykerb's place in treating her2 breast cancer. Anyone else get this? My onc and surgeon are big pioneers in breast cancer and extremely highly regarded in Chicago area.
__________________
~Rina~
Dx:3/06 had a lumpectomy April 19, 2006
Her2+ er/pr- Stage I Grade 3 tumor size 1.4 cm, node negative
AC 4 dense doses
34 radiation treatments including booster doses
receiving herceptin every 3 weeks since late August 2006 for 12 months
|
Threaded Mode